Impact of disasters on blood donation rates and blood safety: A systematic review and meta-analysis.

blood collection blood safety donor health donor motivation transfusion-transmissible infections

Journal

Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606

Informations de publication

Date de publication:
Jun 2022
Historique:
revised: 11 01 2022
received: 21 09 2021
accepted: 11 01 2022
pubmed: 16 2 2022
medline: 18 6 2022
entrez: 15 2 2022
Statut: ppublish

Résumé

Timely and adequate access to safe blood forms an integral part of universal health coverage, but it may be compromised by natural or man-made disasters. This systematic review provides an overview of the best available scientific evidence on the impact of disasters on blood donation rates and safety outcomes. Five databases (The Cochrane Library, MEDLINE, Embase, Web of Science and CINAHL) were searched until 27 March 2020 for (un)controlled studies investigating the impact of disasters on blood donation rates and/or safety. Risk of bias and overall certainty of the evidence were assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. Eighteen observational studies were identified, providing very low certainty of evidence (due to high risk of bias, inconsistency and/or imprecision) on the impact of natural (12 studies) and man-made/technological (6 studies) disasters. The available evidence did not enable us to form any generalizable conclusions on the impact on blood donation rates. Meta-analyses could not detect any statistically significant changes in transfusion-transmissible infection (TTI) rates [hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV)-1/2, human T-lymphotropic virus I and II (HTLV-I/II) and syphilis] in donated blood after a disaster, either in first-time or repeat donors, although the evidence is very uncertain. The very low certainty of evidence synthetized in this systematic review indicates that it is very uncertain whether there is an association between disaster occurrence and changes in TTI rates in donated blood. The currently available evidence did not allow us to draw generalizable conclusions on the impact of disasters on blood donation rates.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Timely and adequate access to safe blood forms an integral part of universal health coverage, but it may be compromised by natural or man-made disasters. This systematic review provides an overview of the best available scientific evidence on the impact of disasters on blood donation rates and safety outcomes.
MATERIALS AND METHODS METHODS
Five databases (The Cochrane Library, MEDLINE, Embase, Web of Science and CINAHL) were searched until 27 March 2020 for (un)controlled studies investigating the impact of disasters on blood donation rates and/or safety. Risk of bias and overall certainty of the evidence were assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.
RESULTS RESULTS
Eighteen observational studies were identified, providing very low certainty of evidence (due to high risk of bias, inconsistency and/or imprecision) on the impact of natural (12 studies) and man-made/technological (6 studies) disasters. The available evidence did not enable us to form any generalizable conclusions on the impact on blood donation rates. Meta-analyses could not detect any statistically significant changes in transfusion-transmissible infection (TTI) rates [hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV)-1/2, human T-lymphotropic virus I and II (HTLV-I/II) and syphilis] in donated blood after a disaster, either in first-time or repeat donors, although the evidence is very uncertain.
CONCLUSION CONCLUSIONS
The very low certainty of evidence synthetized in this systematic review indicates that it is very uncertain whether there is an association between disaster occurrence and changes in TTI rates in donated blood. The currently available evidence did not allow us to draw generalizable conclusions on the impact of disasters on blood donation rates.

Identifiants

pubmed: 35167126
doi: 10.1111/vox.13255
pmc: PMC9306627
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

769-779

Subventions

Organisme : Foundation for Scientific Research of the Belgian Red Cross

Informations de copyright

© 2022 Belgian Red Cross. Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion.

Références

Transfusion. 2003 Nov;43(11):1622-33
pubmed: 14617324
Biologicals. 2010 Jan;38(1):87-90
pubmed: 20149686
Vox Sang. 2022 Jun;117(6):769-779
pubmed: 35167126
Blood Transfus. 2017 Sep;15(5):382-397
pubmed: 28686151
Crit Care Med. 2007 Nov;35(11):2576-81
pubmed: 17828033
Transfusion. 1991 Oct;31(8):719-23
pubmed: 1926316
N Engl J Med. 2002 Feb 21;346(8):617-20
pubmed: 11856803
Vox Sang. 2019 Feb;114(2):137-144
pubmed: 30623977
Transfus Med. 2005 Apr;15(2):93-7
pubmed: 15859974
Transfusion. 2010 Sep;50(9):1972-9
pubmed: 20456694
J Clin Epidemiol. 2011 Apr;64(4):407-15
pubmed: 21247734
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
ISBT Sci Ser. 2017 May;12(2):291-296
pubmed: 28890732
Vox Sang. 2010 Apr;98(3 Pt 1):e219-24
pubmed: 20002621
Rev Panam Salud Publica. 2011 May;29(5):365-70
pubmed: 21709942
JAMA. 2003 May 7;289(17):2246-53
pubmed: 12734136
Vox Sang. 2020 May;115(4):275-287
pubmed: 32043603
Prehosp Disaster Med. 2008 Sep-Oct;23(5):391-4
pubmed: 19189607
Vox Sang. 2018 Apr;113(3):205-219
pubmed: 29243265
Vox Sang. 2012 May;102(4):338-44
pubmed: 21988212
Prehosp Disaster Med. 2015 Oct;30(5):512-22
pubmed: 26451781
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
Transfusion. 2012 Nov;52(11):2321-8
pubmed: 23163293

Auteurs

Jorien Laermans (J)

Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium.

Dorien O (D)

Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium.

Emma Van den Bosch (E)

International Cooperation, Belgian Red Cross, Mechelen, Belgium.

Emmy De Buck (E)

Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium.
Department of Public Health and Primary Care, Faculty of Medicine, KU Leuven, Leuven, Belgium.

Veerle Compernolle (V)

Belgian Red Cross, Blood Services, Mechelen, Belgium.
Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Eilat Shinar (E)

National Blood Services, Magen David Adom, Tel Aviv, Israel.
Ben-Gurion University of the Negev, Beer Sheva, Israel.
Global Advisory Panel on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies (GAP), Perth, Australia.

Philippe Vandekerckhove (P)

Department of Public Health and Primary Care, Faculty of Medicine, KU Leuven, Leuven, Belgium.
Global Advisory Panel on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies (GAP), Perth, Australia.
Belgian Red Cross, Mechelen, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH